New tricyclic systems as photosensitizers towards triple negative breast cancer cells

Arch Pharm Res. 2022 Nov;45(11):806-821. doi: 10.1007/s12272-022-01414-1. Epub 2022 Nov 18.

Abstract

Nineteen pyrrolo[1,2-h][1,7]naphthyridinones and pyrido[2,3-c]pyrrolo[1,2-a]azepinones were synthesized as new tricyclic systems in which the pyridine ring is annelated to the 6,7-dihydroindolizin-8(5H)-one and 5,6,7,8-tetrahydro-9H-pyrrole[1,2-a]azepine-9-one moieties to obtain potential photosensitizing agents. They were tested for their photoantiproliferative activity on a triple-negative breast cancer cell line, MDA-MB-231, in the dark and under UVA light (2.0 J/cm2). We demonstrated that their toxicity, only when exposed to light, was primarily due to the generation of reactive oxygen species while their photodegradation products were not responsible for their activity. The most active compounds exhibited photocytotoxicity with IC50 values at low micromolar level inducing a decrease in the intracellular content of thiol, thus triggering cancer cell death through apoptosis. All the pyridone derivatives revealed to be pure photosensitizers with preferential photocytotoxic activity towards cancerous over healthy cells. Altogether, the results obtained confirm pyrrolo[1,2-h][1,7]naphthyridinones and pyrido[2,3-c]pyrrolo[1,2-a]azepinones as promising photosensitisers against triple-negative breast cancer.

Keywords: MDA-MB-231; Photosensitizing agents; Phototoxic activity; Pyrido[2,3-c]pyrrolo[1,2-a]azepinone; Pyrrolo[1,2-h][1,7]naphthyridinone; Triple-negative breast cancer.

MeSH terms

  • Apoptosis
  • Cell Death
  • Humans
  • Photosensitizing Agents* / pharmacology
  • Reactive Oxygen Species
  • Triple Negative Breast Neoplasms* / drug therapy

Substances

  • Photosensitizing Agents
  • Reactive Oxygen Species